Latest news for Therapeutic Solns Intl (OTC:TSOI) Stock

Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy and traumatic brain injury and Lung Pathology.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ADGO

AFOM

AKER

ANDR

APAAF

ARXRF

ASDN

ASPCF

ASTC

BBGI

BERK

BIEI

BIOC

BRGO

BTLLF

BWSOF

CAMZF

CASA

CBDS

CCTR

CHUC

CIIX

CLABF

CLSN

CNBX

CNSNF

CPPMF

CPPXF

CRNT

CWEGF

DJIFF

DNJR

DPWW

DYNT

EIPC

ELBSF

FBCD

FBEC

FCOB

FELP

FERL

FFNTF

FRLF

GAXY

GGISF

GHIFF

GRST

HABC

HCAP

HCMC

HEWA

HLIX

HPMM

HRTFF

HSDT

HSSHF

HVBTF

INTERNATIONAL ENDEAVORS by International Endeavors Corp

IDVV

IFMK

IMAC

IPICQ

IRNC

ISAT

JCAP

JFIN

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

KWBT

LENSF

LGORF

LLBO

LLLI

LTNC

LUVU

MGWFF

MGXMF

MLHC

MRSN

MYDP

MYHI

NOHO

NUGL

NVSGF

ONCX

ORHOF

OTTV

OZSC

POTRF

PPSI

PTEEF

RAIL

RASFQ

RDWD

RITE

RMSL

RMTI

ROKK

Stocks That Hit 52-Week Lows On Monday

THERAPEUTIC SLTNS INTL by Therapeutic Solutions International, Inc.

Therapeutic Solutions International Inc

Therapeutic Solutions International Inc (TSOI) has released an update. Therapeutic Solutions International, Inc. has officially filed to introduce ...

Therapeutic Solutions Announces New Preferred Stock Filing

Therapeutic Solutions International Inc (TSOI) has released an update. On February 20, 2024, a company successfully amended its Articles of Incorpo...

Therapeutic Solutions Expands Share Authorization

TSOI

Press Releases

Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression

Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease

Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene™

Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy

Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities

Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation

Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product

Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients

Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board

Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases

Therapeutic Solns Intl

Biotech

Therapeutic Solutions International Files Investigational New Drug Application With FDA For Cancer Blood Vessel Targeting Immunotherapy StemVacs-V To Treat Metastatic Breast Cancer

Comments

Therapeutic Solns Intl

News

Latest news for Therapeutic Solns Intl (OTC:TSOI) Stock

Monday, August 30, 2021

Monday, November 04, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga